AI Medical Compendium Journal:
PharmacoEconomics

Showing 1 to 2 of 2 articles

Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?

PharmacoEconomics
OBJECTIVES: Accurate risk stratification of patients with stage II and III colorectal cancer (CRC) prior to treatment selection enables limited health resources to be efficiently allocated to patients who are likely to benefit from adjuvant chemother...

Combining the Power of Artificial Intelligence with the Richness of Healthcare Claims Data: Opportunities and Challenges.

PharmacoEconomics
Combinations of healthcare claims data with additional datasets provide large and rich sources of information. The dimensionality and complexity of these combined datasets can be challenging to handle with standard statistical analyses. However, rece...